Literature DB >> 27599662

Antimicrobial susceptibility and body site distribution of community isolates of coagulase-negative staphylococci.

Jorunn Pauline Cavanagh1,2, Runa Wolden3,4, Philipp Heise5, Eirin Esaiassen3,4, Claus Klingenberg3,4, Elizabeth G Aarag Fredheim6.   

Abstract

The primary aim of this study was to determine antimicrobial resistance in coagulase-negative staphylococci (CoNS) from healthy adults in the community. Healthy adults (n = 114) were swabbed on six body sites; both armpits, both knee pits and both sides of the groin. Species determination was performed using Matrix Assisted Laser Desorption Ionization - Time of Flight (MALDI-TOF) and susceptibility testing for 11 relevant antimicrobials was performed by the disc diffusion method and minimal inhibitory concentration gradient test. In total, 693 CoNS isolates were identified. Susceptibility testing was done on 386 isolates; one CoNS from each species found on each participant from the different body sites. The prevalence of antimicrobial resistance in the CoNS isolates were; erythromycin (24.6%), fusidic acid (19.9%), tetracycline (11.4%), clindamycin (7.8%), gentamicin (6.2%) and cefoxitin (4.1%). Multidrug resistance was observed in 5.2% of the isolates. Staphylococcus epidermidis and S. hominis were the first and second most prevalent species on all three body sites. We conclude that CoNS isolates from healthy adults in the community have a much lower prevalence of antimicrobial resistance than reported in nosocomial CoNS isolates. Still, we believe that levels of resistance in community CoNS should be monitored as the consumption of antimicrobials in primary care in Norway is increasing.
© 2016 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Coagulase-negative staphylococci; antimicrobial resistance; body site distribution; commensals; community CoNS

Mesh:

Substances:

Year:  2016        PMID: 27599662     DOI: 10.1111/apm.12591

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  6 in total

Review 1.  Clinical Infections, Antibiotic Resistance, and Pathogenesis of Staphylococcus haemolyticus.

Authors:  Hala O Eltwisy; Howida Omar Twisy; Mahmoud Hr Hafez; Ibrahim M Sayed; Mohamed A El-Mokhtar
Journal:  Microorganisms       Date:  2022-05-31

Review 2.  Virulence Factors in Coagulase-Negative Staphylococci.

Authors:  Angela França; Vânia Gaio; Nathalie Lopes; Luís D R Melo
Journal:  Pathogens       Date:  2021-02-04

3.  Cutibacterium avidum resists surgical skin antisepsis in the groin-a potential risk factor for periprosthetic joint infection: a quality control study.

Authors:  Steven M Maurer; Laura Kursawe; Stefan Rahm; Julia Prinz; Annelies S Zinkernagel; Annette Moter; Stefan P Kuster; Reinhard Zbinden; Patrick O Zingg; Yvonne Achermann
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-01       Impact factor: 4.887

4.  Antimicrobial Resistance Profiles of Coagulase-Negative Staphylococci in Community-Based Healthy Individuals in Germany.

Authors:  Gabriella Marincola; Olivia Liong; Christoph Schoen; Alaa Abouelfetouh; Aisha Hamdy; Freya D R Wencker; Tessa Marciniak; Karsten Becker; Robin Köck; Wilma Ziebuhr
Journal:  Front Public Health       Date:  2021-06-17

5.  Identifying gram-positive cocci in dermatoscopes and smartphone adapters using MALDI-TOF MS: a cross-sectional study.

Authors:  Maurício de Quadros; Roberto Carlos Freitas Bugs; Renata de Oliveira Soares; Adriana Medianeira Rossato; Lisiane da Luz Rocha; Pedro Alves d'Azevedo
Journal:  An Bras Dermatol       Date:  2020-03-21       Impact factor: 1.896

6.  Identification of surface proteins in a clinical Staphylococcus haemolyticus isolate by bacterial surface shaving.

Authors:  Runa Wolden; Maria Pain; Roger Karlsson; Anders Karlsson; Elizabeth G Aarag Fredheim; Jorunn Pauline Cavanagh
Journal:  BMC Microbiol       Date:  2020-04-07       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.